ID   DPOLL_HUMAN             Reviewed;         575 AA.
AC   Q9UGP5; D3DR76; Q5JQP5; Q6NUM2; Q9BTN8; Q9HA10; Q9HB35;
DT   16-NOV-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   28-JUN-2023, entry version 210.
DE   RecName: Full=DNA polymerase lambda {ECO:0000305};
DE            Short=Pol Lambda {ECO:0000305};
DE            EC=2.7.7.7 {ECO:0000269|PubMed:10887191, ECO:0000269|PubMed:10982892, ECO:0000269|PubMed:12809503, ECO:0000269|PubMed:14627824, ECO:0000269|PubMed:15537631, ECO:0000269|PubMed:19806195};
DE            EC=4.2.99.- {ECO:0000269|PubMed:11457865, ECO:0000269|PubMed:19806195};
DE   AltName: Full=DNA polymerase beta-2 {ECO:0000303|PubMed:10887191};
DE            Short=Pol beta2 {ECO:0000303|PubMed:10887191};
DE   AltName: Full=DNA polymerase kappa {ECO:0000303|Ref.1};
GN   Name=POLL {ECO:0000312|HGNC:HGNC:9184};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RA   Garcia M., Dominguez O., Saniger M.L., Garcia M.J., Martinez C., Bernad A.,
RA   Blanco L.;
RT   "DNA polymerase kappa, a new mammalian meiotic polymerase.";
RL   Submitted (DEC-1998) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, CATALYTIC ACTIVITY, AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Lymph node;
RX   PubMed=10982892; DOI=10.1093/nar/28.18.3684;
RA   Aoufouchi S., Flatter E., Dahan A., Faili A., Bertocci B., Storck S.,
RA   Delbos F., Cocea L., Gupta N., Weill J.-C., Reynaud C.-A.;
RT   "Two novel human and mouse DNA polymerases of the polX family.";
RL   Nucleic Acids Res. 28:3684-3693(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, CATALYTIC ACTIVITY, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=10887191; DOI=10.1074/jbc.m004263200;
RA   Nagasawa K.I., Kitamura K., Yasui A., Nimura Y., Ikeda K., Hirai M.,
RA   Matsukage A., Nakanishi M.;
RT   "Identification and characterization of human DNA polymerase beta 2, a DNA
RT   polymerase beta-related enzyme.";
RL   J. Biol. Chem. 275:31233-31238(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT TRP-438.
RG   NIEHS SNPs program;
RL   Submitted (JUL-2002) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Cahill P., Camire D., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S., Corby N.,
RA   Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L., Frankish A.,
RA   Frankland J.A., Garner P., Garnett J., Gribble S., Griffiths C.,
RA   Grocock R., Gustafson E., Hammond S., Harley J.L., Hart E., Heath P.D.,
RA   Ho T.P., Hopkins B., Horne J., Howden P.J., Huckle E., Hynds C.,
RA   Johnson C., Johnson D., Kana A., Kay M., Kimberley A.M., Kershaw J.K.,
RA   Kokkinaki M., Laird G.K., Lawlor S., Lee H.M., Leongamornlert D.A.,
RA   Laird G., Lloyd C., Lloyd D.M., Loveland J., Lovell J., McLaren S.,
RA   McLay K.E., McMurray A., Mashreghi-Mohammadi M., Matthews L., Milne S.,
RA   Nickerson T., Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V.,
RA   Peck A.I., Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A.,
RA   Ross M.T., Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W., Tracey A.,
RA   Tromans A., Tsolas J., Wall M., Walsh J., Wang H., Weinstock K., West A.P.,
RA   Willey D.L., Whitehead S.L., Wilming L., Wray P.W., Young L., Chen Y.,
RA   Lovering R.C., Moschonas N.K., Siebert R., Fechtel K., Bentley D.,
RA   Durbin R.M., Hubbard T., Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Lung, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 39-575 (ISOFORM 1).
RC   TISSUE=Mammary gland;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [9]
RP   FUNCTION, CATALYTIC ACTIVITY, MUTAGENESIS OF LYS-312, AND ACTIVE SITE.
RX   PubMed=11457865; DOI=10.1074/jbc.m106336200;
RA   Garcia-Diaz M., Bebenek K., Kunkel T.A., Blanco L.;
RT   "Identification of an intrinsic 5'-deoxyribose-5-phosphate lyase activity
RT   in human DNA polymerase lambda: a possible role in base excision repair.";
RL   J. Biol. Chem. 276:34659-34663(2001).
RN   [10]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=12809503; DOI=10.1021/bi034198m;
RA   Blanca G., Shevelev I., Ramadan K., Villani G., Spadari S., Huebscher U.,
RA   Maga G.;
RT   "Human DNA polymerase lambda diverged in evolution from DNA polymerase beta
RT   toward specific Mn(++) dependence: a kinetic and thermodynamic study.";
RL   Biochemistry 42:7467-7476(2003).
RN   [11]
RP   FUNCTION, CATALYTIC ACTIVITY, AND MUTAGENESIS OF TYR-505 AND PHE-506.
RX   PubMed=14627824; DOI=10.1093/nar/gkg896;
RA   Shevelev I., Blanca G., Villani G., Ramadan K., Spadari S., Huebscher U.,
RA   Maga G.;
RT   "Mutagenesis of human DNA polymerase lambda: essential roles of Tyr505 and
RT   Phe506 for both DNA polymerase and terminal transferase activities.";
RL   Nucleic Acids Res. 31:6916-6925(2003).
RN   [12]
RP   INTERACTION WITH PCNA.
RX   PubMed=15358682; DOI=10.1096/fj.04-2268fje;
RA   Maga G., Blanca G., Shevelev I., Frouin I., Ramadan K., Spadari S.,
RA   Villani G., Huebscher U.;
RT   "The human DNA polymerase lambda interacts with PCNA through a domain
RT   important for DNA primer binding and the interaction is inhibited by
RT   p21/WAF1/CIP1.";
RL   FASEB J. 18:1743-1745(2004).
RN   [13]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=15537631; DOI=10.1074/jbc.m411650200;
RA   Maga G., Ramadan K., Locatelli G.A., Shevelev I., Spadari S., Hubscher U.;
RT   "DNA elongation by the human DNA polymerase lambda polymerase and terminal
RT   transferase activities are differentially coordinated by proliferating cell
RT   nuclear antigen and replication protein A.";
RL   J. Biol. Chem. 280:1971-1981(2005).
RN   [14]
RP   FUNCTION, CATALYTIC ACTIVITY, VARIANT TRP-438, CHARACTERIZATION OF VARIANT
RP   TRP-438, AND MUTAGENESIS OF ASP-427 AND ASP-429.
RX   PubMed=19806195; DOI=10.1371/journal.pone.0007290;
RA   Terrados G., Capp J.P., Canitrot Y., Garcia-Diaz M., Bebenek K.,
RA   Kirchhoff T., Villanueva A., Boudsocq F., Bergoglio V., Cazaux C.,
RA   Kunkel T.A., Hoffmann J.S., Blanco L.;
RT   "Characterization of a natural mutator variant of human DNA polymerase
RT   lambda which promotes chromosomal instability by compromising NHEJ.";
RL   PLoS ONE 4:E7290-E7290(2009).
RN   [15]
RP   FUNCTION, AND CHARACTERIZATION OF VARIANT TRP-438.
RX   PubMed=20693240; DOI=10.1093/carcin/bgq166;
RA   Capp J.P., Boudsocq F., Bergoglio V., Trouche D., Cazaux C., Blanco L.,
RA   Hoffmann J.S., Canitrot Y.;
RT   "The R438W polymorphism of human DNA polymerase lambda triggers cellular
RT   sensitivity to camptothecin by compromising the homologous recombination
RT   repair pathway.";
RL   Carcinogenesis 31:1742-1747(2010).
RN   [16]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH XRCC4; PAXX AND NHEJ1.
RX   PubMed=30250067; DOI=10.1038/s41467-018-06127-y;
RA   Craxton A., Munnur D., Jukes-Jones R., Skalka G., Langlais C., Cain K.,
RA   Malewicz M.;
RT   "PAXX and its paralogs synergistically direct DNA polymerase lambda
RT   activity in DNA repair.";
RL   Nat. Commun. 9:3877-3877(2018).
RN   [17]
RP   STRUCTURE BY NMR OF 241-327.
RX   PubMed=12911298; DOI=10.1021/bi034298s;
RA   DeRose E.F., Kirby T.W., Mueller G.A., Bebenek K., Garcia-Diaz M.,
RA   Blanco L., Kunkel T.A., London R.E.;
RT   "Solution structure of the lyase domain of human DNA polymerase lambda.";
RL   Biochemistry 42:9564-9574(2003).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 245-575 IN COMPLEX WITH GAPPED
RP   DNA.
RX   PubMed=14992725; DOI=10.1016/s1097-2765(04)00061-9;
RA   Garcia-Diaz M., Bebenek K., Krahn J.M., Blanco L., Kunkel T.A.,
RA   Pedersen L.C.;
RT   "A structural solution for the DNA polymerase lambda-dependent repair of
RT   DNA gaps with minimal homology.";
RL   Mol. Cell 13:561-572(2004).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF 242-575 IN COMPLEX WITH MANGANESE
RP   AND DCTP.
RX   PubMed=17475573; DOI=10.1016/j.dnarep.2007.03.005;
RA   Garcia-Diaz M., Bebenek K., Krahn J.M., Pedersen L.C., Kunkel T.A.;
RT   "Role of the catalytic metal during polymerization by DNA polymerase
RT   lambda.";
RL   DNA Repair 6:1333-1340(2007).
CC   -!- FUNCTION: DNA polymerase that functions in several pathways of DNA
CC       repair (PubMed:11457865, PubMed:19806195, PubMed:20693240,
CC       PubMed:30250067). Involved in base excision repair (BER) responsible
CC       for repair of lesions that give rise to abasic (AP) sites in DNA
CC       (PubMed:11457865, PubMed:19806195). Also contributes to DNA double-
CC       strand break repair by non-homologous end joining and homologous
CC       recombination (PubMed:19806195, PubMed:20693240, PubMed:30250067). Has
CC       both template-dependent and template-independent (terminal transferase)
CC       DNA polymerase activities (PubMed:10982892, PubMed:10887191,
CC       PubMed:12809503, PubMed:14627824, PubMed:15537631, PubMed:19806195).
CC       Has also a 5'-deoxyribose-5-phosphate lyase (dRP lyase) activity
CC       (PubMed:11457865, PubMed:19806195). {ECO:0000269|PubMed:10887191,
CC       ECO:0000269|PubMed:10982892, ECO:0000269|PubMed:11457865,
CC       ECO:0000269|PubMed:12809503, ECO:0000269|PubMed:14627824,
CC       ECO:0000269|PubMed:15537631, ECO:0000269|PubMed:19806195,
CC       ECO:0000269|PubMed:20693240, ECO:0000269|PubMed:30250067}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 2'-deoxyribonucleoside 5'-triphosphate + DNA(n) =
CC         diphosphate + DNA(n+1); Xref=Rhea:RHEA:22508, Rhea:RHEA-COMP:17339,
CC         Rhea:RHEA-COMP:17340, ChEBI:CHEBI:33019, ChEBI:CHEBI:61560,
CC         ChEBI:CHEBI:173112; EC=2.7.7.7;
CC         Evidence={ECO:0000269|PubMed:10887191, ECO:0000269|PubMed:10982892,
CC         ECO:0000269|PubMed:12809503, ECO:0000269|PubMed:14627824,
CC         ECO:0000269|PubMed:15537631, ECO:0000269|PubMed:19806195};
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000269|PubMed:17475573};
CC   -!- SUBUNIT: Interacts with PCNA (PubMed:14992725). Interacts with PAXX;
CC       promoting POLL recruitment to double-strand breaks (DSBs) and
CC       stimulation of the end-filling activity of POLL (PubMed:30250067).
CC       Interacts with XRCC4; promoting POLL recruitment to double-strand
CC       breaks (DSBs) and stimulation of the end-filling activity of POLL
CC       (PubMed:30250067). Interacts with NHEJ1/XLF; promoting POLL recruitment
CC       to double-strand breaks (DSBs) and stimulation of the end-filling
CC       activity of POLL (PubMed:30250067). {ECO:0000269|PubMed:14992725,
CC       ECO:0000269|PubMed:30250067}.
CC   -!- INTERACTION:
CC       Q9UGP5-2; O95273: CCNDBP1; NbExp=3; IntAct=EBI-10320765, EBI-748961;
CC       Q9UGP5-2; Q96DZ9-2: CMTM5; NbExp=3; IntAct=EBI-10320765, EBI-11522780;
CC       Q9UGP5-2; Q8IZU0: FAM9B; NbExp=3; IntAct=EBI-10320765, EBI-10175124;
CC       Q9UGP5-2; A1L4K1: FSD2; NbExp=4; IntAct=EBI-10320765, EBI-5661036;
CC       Q9UGP5-2; A6NEM1: GOLGA6L9; NbExp=3; IntAct=EBI-10320765, EBI-5916454;
CC       Q9UGP5-2; Q6NT76: HMBOX1; NbExp=3; IntAct=EBI-10320765, EBI-2549423;
CC       Q9UGP5-2; P08779: KRT16; NbExp=3; IntAct=EBI-10320765, EBI-356410;
CC       Q9UGP5-2; P08727: KRT19; NbExp=3; IntAct=EBI-10320765, EBI-742756;
CC       Q9UGP5-2; Q7Z3Y8: KRT27; NbExp=3; IntAct=EBI-10320765, EBI-3044087;
CC       Q9UGP5-2; Q6A162: KRT40; NbExp=3; IntAct=EBI-10320765, EBI-10171697;
CC       Q9UGP5-2; P60409: KRTAP10-7; NbExp=3; IntAct=EBI-10320765, EBI-10172290;
CC       Q9UGP5-2; P80188: LCN2; NbExp=3; IntAct=EBI-10320765, EBI-11911016;
CC       Q9UGP5-2; P43365: MAGEA12; NbExp=6; IntAct=EBI-10320765, EBI-749530;
CC       Q9UGP5-2; P43356: MAGEA2B; NbExp=3; IntAct=EBI-10320765, EBI-5650739;
CC       Q9UGP5-2; Q969L2: MAL2; NbExp=3; IntAct=EBI-10320765, EBI-944295;
CC       Q9UGP5-2; P23508: MCC; NbExp=3; IntAct=EBI-10320765, EBI-307531;
CC       Q9UGP5-2; Q99750: MDFI; NbExp=3; IntAct=EBI-10320765, EBI-724076;
CC       Q9UGP5-2; Q9NRD5: PICK1; NbExp=3; IntAct=EBI-10320765, EBI-79165;
CC       Q9UGP5-2; Q8ND90: PNMA1; NbExp=3; IntAct=EBI-10320765, EBI-302345;
CC       Q9UGP5-2; O94806-2: PRKD3; NbExp=3; IntAct=EBI-10320765, EBI-13337369;
CC       Q9UGP5-2; Q9Y2D8: SSX2IP; NbExp=3; IntAct=EBI-10320765, EBI-2212028;
CC       Q9UGP5-2; Q12800: TFCP2; NbExp=3; IntAct=EBI-10320765, EBI-717422;
CC       Q9UGP5-2; Q9UBB9: TFIP11; NbExp=3; IntAct=EBI-10320765, EBI-1105213;
CC       Q9UGP5-2; Q9UBN6: TNFRSF10D; NbExp=3; IntAct=EBI-10320765, EBI-1044859;
CC       Q9UGP5-2; P36406: TRIM23; NbExp=3; IntAct=EBI-10320765, EBI-740098;
CC       Q9UGP5-2; Q9UGI0: ZRANB1; NbExp=3; IntAct=EBI-10320765, EBI-527853;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10887191}. Chromosome
CC       {ECO:0000269|PubMed:30250067}. Note=Accumulates at sites of DNA damage.
CC       {ECO:0000269|PubMed:30250067}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9UGP5-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UGP5-2; Sequence=VSP_056540, VSP_056541;
CC   -!- TISSUE SPECIFICITY: Expressed in a number of tissues. Abundant in
CC       testis. {ECO:0000269|PubMed:10982892}.
CC   -!- SIMILARITY: Belongs to the DNA polymerase type-X family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB14050.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/poll/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ131890; CAB65074.1; -; mRNA.
DR   EMBL; AF161019; AAF27541.1; -; mRNA.
DR   EMBL; AF283478; AAG22519.1; -; mRNA.
DR   EMBL; AF525924; AAM77696.1; -; Genomic_DNA.
DR   EMBL; AL627424; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471066; EAW49759.1; -; Genomic_DNA.
DR   EMBL; CH471066; EAW49760.1; -; Genomic_DNA.
DR   EMBL; CH471066; EAW49766.1; -; Genomic_DNA.
DR   EMBL; CH471066; EAW49768.1; -; Genomic_DNA.
DR   EMBL; BC003548; AAH03548.2; -; mRNA.
DR   EMBL; BC068529; AAH68529.1; -; mRNA.
DR   EMBL; AK022476; BAB14050.1; ALT_INIT; mRNA.
DR   CCDS; CCDS7513.1; -. [Q9UGP5-1]
DR   CCDS; CCDS76332.1; -. [Q9UGP5-2]
DR   RefSeq; NP_001167555.1; NM_001174084.1. [Q9UGP5-1]
DR   RefSeq; NP_001167556.1; NM_001174085.1.
DR   RefSeq; NP_001295311.1; NM_001308382.1. [Q9UGP5-2]
DR   RefSeq; NP_037406.1; NM_013274.3. [Q9UGP5-1]
DR   RefSeq; XP_006717840.1; XM_006717777.1. [Q9UGP5-2]
DR   RefSeq; XP_011537953.1; XM_011539651.1. [Q9UGP5-1]
DR   PDB; 1NZP; NMR; -; A=242-327.
DR   PDB; 1RZT; X-ray; 2.10 A; A/E/I/M=245-575.
DR   PDB; 1XSL; X-ray; 2.30 A; A/E/I/M=242-575.
DR   PDB; 1XSN; X-ray; 1.95 A; A=242-575.
DR   PDB; 1XSP; X-ray; 2.20 A; A=242-575.
DR   PDB; 2BCQ; X-ray; 1.65 A; A=242-575.
DR   PDB; 2BCR; X-ray; 1.75 A; A=242-575.
DR   PDB; 2BCS; X-ray; 2.20 A; A=242-575.
DR   PDB; 2BCU; X-ray; 2.20 A; A=242-575.
DR   PDB; 2BCV; X-ray; 2.00 A; A=242-575.
DR   PDB; 2GWS; X-ray; 2.40 A; A/E/I/M=242-575.
DR   PDB; 2JW5; NMR; -; A=34-135.
DR   PDB; 2PFN; X-ray; 1.90 A; A=242-575.
DR   PDB; 2PFO; X-ray; 2.00 A; A=242-575.
DR   PDB; 2PFP; X-ray; 2.10 A; A=242-575.
DR   PDB; 2PFQ; X-ray; 2.10 A; A=242-575.
DR   PDB; 3C5F; X-ray; 2.25 A; A/B=242-575.
DR   PDB; 3C5G; X-ray; 2.20 A; A/B=242-575.
DR   PDB; 3HW8; X-ray; 1.95 A; A=242-575.
DR   PDB; 3HWT; X-ray; 1.95 A; A=242-575.
DR   PDB; 3HX0; X-ray; 3.00 A; A/F/K/P=242-575.
DR   PDB; 3MDA; X-ray; 2.03 A; A=252-575.
DR   PDB; 3MDC; X-ray; 2.00 A; A=252-575.
DR   PDB; 3MGH; X-ray; 2.40 A; A/C=242-575.
DR   PDB; 3MGI; X-ray; 2.60 A; A=242-575.
DR   PDB; 3PML; X-ray; 2.60 A; A/B=242-575.
DR   PDB; 3PMN; X-ray; 2.20 A; A=242-575.
DR   PDB; 3PNC; X-ray; 2.00 A; A=242-575.
DR   PDB; 3UPQ; X-ray; 1.95 A; A=242-575.
DR   PDB; 3UQ0; X-ray; 2.14 A; A=242-575.
DR   PDB; 3UQ2; X-ray; 2.25 A; A=242-575.
DR   PDB; 4FO6; X-ray; 2.01 A; A=242-575.
DR   PDB; 4K4G; X-ray; 2.15 A; A/E/I/M=245-575.
DR   PDB; 4K4H; X-ray; 2.10 A; A/E/I/M=245-575.
DR   PDB; 4K4I; X-ray; 2.25 A; A/E/I/M=245-575.
DR   PDB; 4X5V; X-ray; 2.15 A; A=251-575.
DR   PDB; 4XA5; X-ray; 1.90 A; A=251-575.
DR   PDB; 4XQ8; X-ray; 2.80 A; A/B=242-575.
DR   PDB; 4XRH; X-ray; 3.00 A; A/B=242-575.
DR   PDB; 4XUS; X-ray; 2.40 A; A=251-575.
DR   PDB; 5CA7; X-ray; 2.52 A; A/B=242-575.
DR   PDB; 5CB1; X-ray; 3.30 A; A/B=250-575.
DR   PDB; 5CHG; X-ray; 2.90 A; A/B=242-575.
DR   PDB; 5CJ7; X-ray; 2.90 A; A/B=242-575.
DR   PDB; 5CP2; X-ray; 2.36 A; A/B=242-575.
DR   PDB; 5CR0; X-ray; 2.75 A; A/B=242-575.
DR   PDB; 5CWR; X-ray; 2.50 A; A/B=250-575.
DR   PDB; 5DDM; X-ray; 2.80 A; A/B=242-575.
DR   PDB; 5DDY; X-ray; 3.36 A; A/C/E/G=242-575.
DR   PDB; 5DKW; X-ray; 2.69 A; A/B=249-575.
DR   PDB; 5III; X-ray; 1.80 A; A=242-575.
DR   PDB; 5IIJ; X-ray; 1.72 A; A=242-575.
DR   PDB; 5IIK; X-ray; 1.98 A; A=242-575.
DR   PDB; 5IIL; X-ray; 1.96 A; A=242-575.
DR   PDB; 5IIM; X-ray; 1.94 A; A=242-575.
DR   PDB; 5IIN; X-ray; 2.15 A; A=242-575.
DR   PDB; 5IIO; X-ray; 2.08 A; A/E/I/M=242-575.
DR   PDB; 5W4G; X-ray; 2.04 A; A=4-32.
DR   PDB; 7M07; X-ray; 1.57 A; A=234-575.
DR   PDB; 7M08; X-ray; 1.70 A; A=234-575.
DR   PDB; 7M09; X-ray; 1.65 A; A=234-575.
DR   PDB; 7M0A; X-ray; 1.83 A; A=234-575.
DR   PDB; 7M0B; X-ray; 2.00 A; A=234-575.
DR   PDB; 7M0C; X-ray; 2.65 A; A=234-575.
DR   PDB; 7M0D; X-ray; 1.80 A; A/B=234-575.
DR   PDB; 7M0E; X-ray; 2.25 A; A/B/C/D=232-575.
DR   PDB; 7M43; X-ray; 1.98 A; A=242-575.
DR   PDB; 7M44; X-ray; 1.90 A; A=242-575.
DR   PDB; 7M45; X-ray; 1.89 A; A=242-575.
DR   PDB; 7M46; X-ray; 1.92 A; A=242-575.
DR   PDB; 7M47; X-ray; 1.65 A; A=242-575.
DR   PDB; 7M48; X-ray; 1.93 A; A=242-575.
DR   PDB; 7M49; X-ray; 1.60 A; A=242-575.
DR   PDB; 7M4A; X-ray; 1.87 A; A=242-575.
DR   PDB; 7M4B; X-ray; 1.66 A; A=242-575.
DR   PDB; 7M4C; X-ray; 1.95 A; A=242-575.
DR   PDB; 7M4D; X-ray; 1.82 A; A=242-575.
DR   PDB; 7M4E; X-ray; 1.90 A; A=242-575.
DR   PDB; 7M4F; X-ray; 1.95 A; A=242-575.
DR   PDB; 7M4G; X-ray; 1.88 A; A=242-575.
DR   PDB; 7M4H; X-ray; 1.92 A; A=242-575.
DR   PDB; 7M4I; X-ray; 2.00 A; A=242-575.
DR   PDB; 7M4J; X-ray; 2.38 A; A=242-575.
DR   PDB; 7M4K; X-ray; 1.72 A; A=242-575.
DR   PDB; 7M4L; X-ray; 1.70 A; A=242-575.
DR   PDB; 7UN7; X-ray; 2.04 A; A=242-575.
DR   PDBsum; 1NZP; -.
DR   PDBsum; 1RZT; -.
DR   PDBsum; 1XSL; -.
DR   PDBsum; 1XSN; -.
DR   PDBsum; 1XSP; -.
DR   PDBsum; 2BCQ; -.
DR   PDBsum; 2BCR; -.
DR   PDBsum; 2BCS; -.
DR   PDBsum; 2BCU; -.
DR   PDBsum; 2BCV; -.
DR   PDBsum; 2GWS; -.
DR   PDBsum; 2JW5; -.
DR   PDBsum; 2PFN; -.
DR   PDBsum; 2PFO; -.
DR   PDBsum; 2PFP; -.
DR   PDBsum; 2PFQ; -.
DR   PDBsum; 3C5F; -.
DR   PDBsum; 3C5G; -.
DR   PDBsum; 3HW8; -.
DR   PDBsum; 3HWT; -.
DR   PDBsum; 3HX0; -.
DR   PDBsum; 3MDA; -.
DR   PDBsum; 3MDC; -.
DR   PDBsum; 3MGH; -.
DR   PDBsum; 3MGI; -.
DR   PDBsum; 3PML; -.
DR   PDBsum; 3PMN; -.
DR   PDBsum; 3PNC; -.
DR   PDBsum; 3UPQ; -.
DR   PDBsum; 3UQ0; -.
DR   PDBsum; 3UQ2; -.
DR   PDBsum; 4FO6; -.
DR   PDBsum; 4K4G; -.
DR   PDBsum; 4K4H; -.
DR   PDBsum; 4K4I; -.
DR   PDBsum; 4X5V; -.
DR   PDBsum; 4XA5; -.
DR   PDBsum; 4XQ8; -.
DR   PDBsum; 4XRH; -.
DR   PDBsum; 4XUS; -.
DR   PDBsum; 5CA7; -.
DR   PDBsum; 5CB1; -.
DR   PDBsum; 5CHG; -.
DR   PDBsum; 5CJ7; -.
DR   PDBsum; 5CP2; -.
DR   PDBsum; 5CR0; -.
DR   PDBsum; 5CWR; -.
DR   PDBsum; 5DDM; -.
DR   PDBsum; 5DDY; -.
DR   PDBsum; 5DKW; -.
DR   PDBsum; 5III; -.
DR   PDBsum; 5IIJ; -.
DR   PDBsum; 5IIK; -.
DR   PDBsum; 5IIL; -.
DR   PDBsum; 5IIM; -.
DR   PDBsum; 5IIN; -.
DR   PDBsum; 5IIO; -.
DR   PDBsum; 5W4G; -.
DR   PDBsum; 7M07; -.
DR   PDBsum; 7M08; -.
DR   PDBsum; 7M09; -.
DR   PDBsum; 7M0A; -.
DR   PDBsum; 7M0B; -.
DR   PDBsum; 7M0C; -.
DR   PDBsum; 7M0D; -.
DR   PDBsum; 7M0E; -.
DR   PDBsum; 7M43; -.
DR   PDBsum; 7M44; -.
DR   PDBsum; 7M45; -.
DR   PDBsum; 7M46; -.
DR   PDBsum; 7M47; -.
DR   PDBsum; 7M48; -.
DR   PDBsum; 7M49; -.
DR   PDBsum; 7M4A; -.
DR   PDBsum; 7M4B; -.
DR   PDBsum; 7M4C; -.
DR   PDBsum; 7M4D; -.
DR   PDBsum; 7M4E; -.
DR   PDBsum; 7M4F; -.
DR   PDBsum; 7M4G; -.
DR   PDBsum; 7M4H; -.
DR   PDBsum; 7M4I; -.
DR   PDBsum; 7M4J; -.
DR   PDBsum; 7M4K; -.
DR   PDBsum; 7M4L; -.
DR   PDBsum; 7UN7; -.
DR   AlphaFoldDB; Q9UGP5; -.
DR   BMRB; Q9UGP5; -.
DR   SMR; Q9UGP5; -.
DR   BioGRID; 118155; 70.
DR   DIP; DIP-48999N; -.
DR   IntAct; Q9UGP5; 41.
DR   MINT; Q9UGP5; -.
DR   STRING; 9606.ENSP00000359181; -.
DR   BindingDB; Q9UGP5; -.
DR   ChEMBL; CHEMBL5367; -.
DR   GlyGen; Q9UGP5; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q9UGP5; -.
DR   PhosphoSitePlus; Q9UGP5; -.
DR   BioMuta; POLL; -.
DR   DMDM; 17367126; -.
DR   EPD; Q9UGP5; -.
DR   jPOST; Q9UGP5; -.
DR   MassIVE; Q9UGP5; -.
DR   MaxQB; Q9UGP5; -.
DR   PaxDb; Q9UGP5; -.
DR   PeptideAtlas; Q9UGP5; -.
DR   ProteomicsDB; 79002; -.
DR   ProteomicsDB; 84253; -. [Q9UGP5-1]
DR   Antibodypedia; 31295; 282 antibodies from 33 providers.
DR   DNASU; 27343; -.
DR   Ensembl; ENST00000299206.8; ENSP00000299206.4; ENSG00000166169.17. [Q9UGP5-1]
DR   Ensembl; ENST00000370162.8; ENSP00000359181.3; ENSG00000166169.17. [Q9UGP5-1]
DR   Ensembl; ENST00000370169.5; ENSP00000359188.1; ENSG00000166169.17. [Q9UGP5-1]
DR   Ensembl; ENST00000628479.2; ENSP00000485885.1; ENSG00000166169.17. [Q9UGP5-2]
DR   GeneID; 27343; -.
DR   KEGG; hsa:27343; -.
DR   MANE-Select; ENST00000370162.8; ENSP00000359181.3; NM_001174084.2; NP_001167555.1.
DR   UCSC; uc001ktg.2; human. [Q9UGP5-1]
DR   AGR; HGNC:9184; -.
DR   CTD; 27343; -.
DR   DisGeNET; 27343; -.
DR   GeneCards; POLL; -.
DR   HGNC; HGNC:9184; POLL.
DR   HPA; ENSG00000166169; Low tissue specificity.
DR   MIM; 606343; gene.
DR   neXtProt; NX_Q9UGP5; -.
DR   OpenTargets; ENSG00000166169; -.
DR   PharmGKB; PA33504; -.
DR   VEuPathDB; HostDB:ENSG00000166169; -.
DR   eggNOG; KOG2534; Eukaryota.
DR   GeneTree; ENSGT00940000158515; -.
DR   InParanoid; Q9UGP5; -.
DR   OMA; KWHGASA; -.
DR   OrthoDB; 49764at2759; -.
DR   PhylomeDB; Q9UGP5; -.
DR   TreeFam; TF103011; -.
DR   BRENDA; 4.2.99.B1; 2681.
DR   PathwayCommons; Q9UGP5; -.
DR   Reactome; R-HSA-5693571; Nonhomologous End-Joining (NHEJ).
DR   SABIO-RK; Q9UGP5; -.
DR   SignaLink; Q9UGP5; -.
DR   BioGRID-ORCS; 27343; 14 hits in 1157 CRISPR screens.
DR   ChiTaRS; POLL; human.
DR   EvolutionaryTrace; Q9UGP5; -.
DR   GeneWiki; DNA_polymerase_lambda; -.
DR   GenomeRNAi; 27343; -.
DR   Pharos; Q9UGP5; Tbio.
DR   PRO; PR:Q9UGP5; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   RNAct; Q9UGP5; protein.
DR   Bgee; ENSG00000166169; Expressed in right uterine tube and 161 other tissues.
DR   ExpressionAtlas; Q9UGP5; baseline and differential.
DR   Genevisible; Q9UGP5; HS.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0035861; C:site of double-strand break; IDA:UniProtKB.
DR   GO; GO:0051575; F:5'-deoxyribose-5-phosphate lyase activity; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; NAS:UniProtKB.
DR   GO; GO:0003887; F:DNA-directed DNA polymerase activity; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006287; P:base-excision repair, gap-filling; IDA:UniProtKB.
DR   GO; GO:0071897; P:DNA biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0006260; P:DNA replication; NAS:UniProtKB.
DR   GO; GO:0000724; P:double-strand break repair via homologous recombination; IMP:UniProtKB.
DR   GO; GO:0006303; P:double-strand break repair via nonhomologous end joining; IDA:UniProtKB.
DR   GO; GO:0006289; P:nucleotide-excision repair; IDA:UniProtKB.
DR   GO; GO:0016446; P:somatic hypermutation of immunoglobulin genes; NAS:UniProtKB.
DR   CDD; cd17715; BRCT_polymerase_lambda; 1.
DR   CDD; cd00141; NT_POLXc; 1.
DR   Gene3D; 1.10.150.20; 5' to 3' exonuclease, C-terminal subdomain; 1.
DR   Gene3D; 3.30.460.10; Beta Polymerase, domain 2; 1.
DR   Gene3D; 3.40.50.10190; BRCT domain; 1.
DR   Gene3D; 1.10.150.110; DNA polymerase beta, N-terminal domain-like; 1.
DR   Gene3D; 3.30.210.10; DNA polymerase, thumb domain; 1.
DR   InterPro; IPR001357; BRCT_dom.
DR   InterPro; IPR036420; BRCT_dom_sf.
DR   InterPro; IPR002054; DNA-dir_DNA_pol_X.
DR   InterPro; IPR019843; DNA_pol-X_BS.
DR   InterPro; IPR010996; DNA_pol_b-like_N.
DR   InterPro; IPR028207; DNA_pol_B_palm_palm.
DR   InterPro; IPR018944; DNA_pol_lambd_fingers_domain.
DR   InterPro; IPR027421; DNA_pol_lamdba_lyase_dom_sf.
DR   InterPro; IPR037160; DNA_Pol_thumb_sf.
DR   InterPro; IPR022312; DNA_pol_X.
DR   InterPro; IPR002008; DNA_pol_X_beta-like.
DR   InterPro; IPR043519; NT_sf.
DR   InterPro; IPR029398; PolB_thumb.
DR   PANTHER; PTHR11276:SF28; DNA POLYMERASE LAMBDA; 1.
DR   PANTHER; PTHR11276; DNA POLYMERASE TYPE-X FAMILY MEMBER; 1.
DR   Pfam; PF14792; DNA_pol_B_palm; 1.
DR   Pfam; PF14791; DNA_pol_B_thumb; 1.
DR   Pfam; PF10391; DNA_pol_lambd_f; 1.
DR   Pfam; PF14716; HHH_8; 1.
DR   PRINTS; PR00869; DNAPOLX.
DR   PRINTS; PR00870; DNAPOLXBETA.
DR   SMART; SM00483; POLXc; 1.
DR   SUPFAM; SSF52113; BRCT domain; 1.
DR   SUPFAM; SSF47802; DNA polymerase beta, N-terminal domain-like; 1.
DR   SUPFAM; SSF81301; Nucleotidyltransferase; 1.
DR   SUPFAM; SSF81585; PsbU/PolX domain-like; 1.
DR   PROSITE; PS50172; BRCT; 1.
DR   PROSITE; PS00522; DNA_POLYMERASE_X; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Chromosome; DNA damage; DNA repair;
KW   DNA replication; DNA synthesis; DNA-binding; DNA-directed DNA polymerase;
KW   Lyase; Manganese; Metal-binding; Nucleotidyltransferase; Nucleus;
KW   Reference proteome; Transferase.
FT   CHAIN           1..575
FT                   /note="DNA polymerase lambda"
FT                   /id="PRO_0000218783"
FT   DOMAIN          36..132
FT                   /note="BRCT"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00033"
FT   REGION          161..205
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          265..279
FT                   /note="DNA-binding"
FT                   /evidence="ECO:0000269|PubMed:14992725"
FT   REGION          345..348
FT                   /note="DNA-binding"
FT                   /evidence="ECO:0000269|PubMed:14992725"
FT   REGION          420..429
FT                   /note="Involved in primer binding"
FT                   /evidence="ECO:0000250"
FT   REGION          466..505
FT                   /note="DNA-binding"
FT                   /evidence="ECO:0000269|PubMed:14992725"
FT   COMPBIAS        165..179
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        312
FT                   /note="Schiff-base intermediate with DNA"
FT                   /evidence="ECO:0000269|PubMed:11457865"
FT   BINDING         386
FT                   /ligand="dCTP"
FT                   /ligand_id="ChEBI:CHEBI:61481"
FT                   /evidence="ECO:0000269|PubMed:17475573,
FT                   ECO:0007744|PDB:2PFP, ECO:0007744|PDB:2PFQ"
FT   BINDING         417..420
FT                   /ligand="dCTP"
FT                   /ligand_id="ChEBI:CHEBI:61481"
FT                   /evidence="ECO:0000269|PubMed:17475573,
FT                   ECO:0007744|PDB:2PFP, ECO:0007744|PDB:2PFQ"
FT   BINDING         426..429
FT                   /ligand="dCTP"
FT                   /ligand_id="ChEBI:CHEBI:61481"
FT                   /evidence="ECO:0000269|PubMed:17475573,
FT                   ECO:0007744|PDB:2PFP, ECO:0007744|PDB:2PFQ"
FT   BINDING         427
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /evidence="ECO:0000269|PubMed:17475573,
FT                   ECO:0007744|PDB:2PFO, ECO:0007744|PDB:2PFQ"
FT   BINDING         429
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /evidence="ECO:0000269|PubMed:17475573,
FT                   ECO:0007744|PDB:2PFO, ECO:0007744|PDB:2PFQ"
FT   BINDING         490
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /evidence="ECO:0000269|PubMed:17475573,
FT                   ECO:0007744|PDB:2PFO, ECO:0007744|PDB:2PFQ"
FT   BINDING         513
FT                   /ligand="dCTP"
FT                   /ligand_id="ChEBI:CHEBI:61481"
FT                   /evidence="ECO:0000269|PubMed:17475573,
FT                   ECO:0007744|PDB:2PFP, ECO:0007744|PDB:2PFQ"
FT   VAR_SEQ         1..22
FT                   /note="MDPRGILKAFPKRQKIHADASS -> MLMHHQKYLQRFLGGKREKKQK (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_056540"
FT   VAR_SEQ         23..297
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_056541"
FT   VARIANT         221
FT                   /note="T -> P (in dbSNP:rs3730463)"
FT                   /id="VAR_020268"
FT   VARIANT         438
FT                   /note="R -> W (changed DNA polymerase activity
FT                   characterized by decreased fidelity and unchanged
FT                   polymerization capacity; changed function in DNA
FT                   double-strand break repair by non-homologous end joining
FT                   and homologous recombination; no effect on
FT                   5'-deoxyribose-5-phosphate lyase activity;
FT                   dbSNP:rs3730477)"
FT                   /evidence="ECO:0000269|PubMed:19806195,
FT                   ECO:0000269|PubMed:20693240, ECO:0000269|Ref.4"
FT                   /id="VAR_020269"
FT   MUTAGEN         312
FT                   /note="K->A: Reduces dRP lyase activity by over 90%."
FT                   /evidence="ECO:0000269|PubMed:11457865"
FT   MUTAGEN         427
FT                   /note="D->A: Loss of polymerase activity; when associated
FT                   with A-429."
FT                   /evidence="ECO:0000269|PubMed:19806195"
FT   MUTAGEN         429
FT                   /note="D->A: Loss of polymerase activity; when associated
FT                   with A-427."
FT                   /evidence="ECO:0000269|PubMed:19806195"
FT   MUTAGEN         505
FT                   /note="Y->A: No effect on polymerase activity. Reduces
FT                   terminal transferase activities."
FT                   /evidence="ECO:0000269|PubMed:14627824"
FT   MUTAGEN         506
FT                   /note="F->G,R: Strongly reduces polymerase and terminal
FT                   transferase activities."
FT                   /evidence="ECO:0000269|PubMed:14627824"
FT   CONFLICT        138
FT                   /note="Y -> C (in Ref. 3; AAG22519)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        298
FT                   /note="E -> G (in Ref. 7; AAH68529)"
FT                   /evidence="ECO:0000305"
FT   HELIX           37..39
FT                   /evidence="ECO:0007829|PDB:2JW5"
FT   HELIX           41..43
FT                   /evidence="ECO:0007829|PDB:2JW5"
FT   TURN            50..52
FT                   /evidence="ECO:0007829|PDB:2JW5"
FT   STRAND          55..57
FT                   /evidence="ECO:0007829|PDB:2JW5"
FT   HELIX           60..67
FT                   /evidence="ECO:0007829|PDB:2JW5"
FT   STRAND          82..85
FT                   /evidence="ECO:0007829|PDB:2JW5"
FT   STRAND          87..89
FT                   /evidence="ECO:0007829|PDB:2JW5"
FT   HELIX           91..97
FT                   /evidence="ECO:0007829|PDB:2JW5"
FT   STRAND          108..111
FT                   /evidence="ECO:0007829|PDB:2JW5"
FT   HELIX           112..120
FT                   /evidence="ECO:0007829|PDB:2JW5"
FT   HELIX           127..129
FT                   /evidence="ECO:0007829|PDB:2JW5"
FT   HELIX           240..242
FT                   /evidence="ECO:0007829|PDB:7M08"
FT   HELIX           245..248
FT                   /evidence="ECO:0007829|PDB:7M08"
FT   HELIX           254..269
FT                   /evidence="ECO:0007829|PDB:7M49"
FT   HELIX           273..287
FT                   /evidence="ECO:0007829|PDB:7M49"
FT   STRAND          289..291
FT                   /evidence="ECO:0007829|PDB:7M08"
FT   HELIX           296..299
FT                   /evidence="ECO:0007829|PDB:7M49"
FT   HELIX           307..319
FT                   /evidence="ECO:0007829|PDB:7M49"
FT   HELIX           323..327
FT                   /evidence="ECO:0007829|PDB:7M49"
FT   HELIX           332..339
FT                   /evidence="ECO:0007829|PDB:7M49"
FT   HELIX           346..354
FT                   /evidence="ECO:0007829|PDB:7M49"
FT   HELIX           360..366
FT                   /evidence="ECO:0007829|PDB:7M49"
FT   HELIX           371..378
FT                   /evidence="ECO:0007829|PDB:7M49"
FT   HELIX           380..383
FT                   /evidence="ECO:0007829|PDB:7M49"
FT   HELIX           389..404
FT                   /evidence="ECO:0007829|PDB:7M49"
FT   STRAND          411..414
FT                   /evidence="ECO:0007829|PDB:7M49"
FT   HELIX           416..419
FT                   /evidence="ECO:0007829|PDB:7M49"
FT   STRAND          423..433
FT                   /evidence="ECO:0007829|PDB:7M49"
FT   STRAND          435..438
FT                   /evidence="ECO:0007829|PDB:4X5V"
FT   TURN            439..442
FT                   /evidence="ECO:0007829|PDB:7M49"
FT   HELIX           444..453
FT                   /evidence="ECO:0007829|PDB:7M49"
FT   STRAND          457..463
FT                   /evidence="ECO:0007829|PDB:7M49"
FT   STRAND          466..468
FT                   /evidence="ECO:0007829|PDB:7M08"
FT   STRAND          471..477
FT                   /evidence="ECO:0007829|PDB:7M49"
FT   STRAND          480..483
FT                   /evidence="ECO:0007829|PDB:4XA5"
FT   STRAND          487..493
FT                   /evidence="ECO:0007829|PDB:7M49"
FT   HELIX           496..498
FT                   /evidence="ECO:0007829|PDB:7M49"
FT   HELIX           499..507
FT                   /evidence="ECO:0007829|PDB:7M49"
FT   HELIX           510..522
FT                   /evidence="ECO:0007829|PDB:7M49"
FT   STRAND          525..527
FT                   /evidence="ECO:0007829|PDB:7M49"
FT   STRAND          532..535
FT                   /evidence="ECO:0007829|PDB:7M49"
FT   STRAND          539..542
FT                   /evidence="ECO:0007829|PDB:7M4H"
FT   STRAND          544..546
FT                   /evidence="ECO:0007829|PDB:7M49"
FT   STRAND          549..551
FT                   /evidence="ECO:0007829|PDB:7M47"
FT   HELIX           556..562
FT                   /evidence="ECO:0007829|PDB:7M49"
FT   HELIX           570..573
FT                   /evidence="ECO:0007829|PDB:7M49"
SQ   SEQUENCE   575 AA;  63482 MW;  FD9196A1C94923C4 CRC64;
     MDPRGILKAF PKRQKIHADA SSKVLAKIPR REEGEEAEEW LSSLRAHVVR TGIGRARAEL
     FEKQIVQHGG QLCPAQGPGV THIVVDEGMD YERALRLLRL PQLPPGAQLV KSAWLSLCLQ
     ERRLVDVAGF SIFIPSRYLD HPQPSKAEQD ASIPPGTHEA LLQTALSPPP PPTRPVSPPQ
     KAKEAPNTQA QPISDDEASD GEETQVSAAD LEALISGHYP TSLEGDCEPS PAPAVLDKWV
     CAQPSSQKAT NHNLHITEKL EVLAKAYSVQ GDKWRALGYA KAINALKSFH KPVTSYQEAC
     SIPGIGKRMA EKIIEILESG HLRKLDHISE SVPVLELFSN IWGAGTKTAQ MWYQQGFRSL
     EDIRSQASLT TQQAIGLKHY SDFLERMPRE EATEIEQTVQ KAAQAFNSGL LCVACGSYRR
     GKATCGDVDV LITHPDGRSH RGIFSRLLDS LRQEGFLTDD LVSQEENGQQ QKYLGVCRLP
     GPGRRHRRLD IIVVPYSEFA CALLYFTGSA HFNRSMRALA KTKGMSLSEH ALSTAVVRNT
     HGCKVGPGRV LPTPTEKDVF RLLGLPYREP AERDW
//
